|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 19/10 | |||
| A61K 45/06 | |||
| C07K 14/52 | |||
| C07K 14/705 |
| (11) | Patento numeris | 3184545 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16198812.6 |
| Europos patento paraiškos padavimo data | 2001-02-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 511139 | 2000-02-23 | US | |
| 791153 | 2001-02-22 | US |
| (72) |
Deshpande, Rajendra V., US
Hitz, Anna, US
Boyle, William J., US
Sullivan, John K., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | ANTAGONISTIC SELECTIVE BINDING AGENTS OF OSTEOPROTEGERIN BINDING PROTEIN |
| ANTAGONISTIC SELECTIVE BINDING AGENTS OF OSTEOPROTEGERIN BINDING PROTEIN |